The secret behind successful proximity ligation is careful preparation, with a special focus on antibody selection. Navinci, formerly known as Olink Biosciences, has a proud history as developers of the first commercial in situ proximity ligation assay, the Duolink assay (now sold to Sigma). The next-generation Naveni proximity ligation assays are based on a new, proprietary technology providing higher sensitivity and less unspecific background than traditional PLA. The developers of the Naveni technology are still actively working on new technology development in our R&D laboratory in Uppsala, which gives us the possibility to provide state-of-the-art technical support to our customers. Please contact us through the form below with any questions you might have before ordering, or after you have started your studies.

Contact the Navinci support team